- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.03. | AbbVie takes Genmab to court, accusing partner of being 'willfully blind' to ADC trade secret theft | ||
| 24.03. | Opthea's eye disease drug defeated by Eylea in phase 3, leaving biotech to mull future | ||
| 21.03. | Chimerix engaged with 7 other biopharmas before choosing Jazz's $935M deal-here's why it won | ||
| 21.03. | Nvidia outlines new AI projects in robotic surgery, autonomous imaging | ||
| 21.03. | European countries, universities implement initiatives to attract US researchers amid 'brutal funding cuts' | ||
| 21.03. | Vaxart lays off 10% of staff after HHS unexpectedly demands halt to COVID vaccine trial | ||
| 21.03. | AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts | ||
| 21.03. | Eisai's abandoned Enhertu challenger set to live on at BlissBio | ||
| 21.03. | MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data | ||
| 20.03. | British investment firm secures $250M to help fund development of new dementia therapeutics | ||
| 20.03. | Adaptimmune, after bringing cell therapy to market, questions viability and cuts 2 preclinical programs | ||
| 20.03. | Insulet Type 1 diabetes study shows gains in 3 months after starting first automated insulin pump | ||
| 20.03. | Elevation drops sole clinical-stage ADC over poor phase 1 data, lays off 70% of staff | ||
| 20.03. | Monte Rosa's broad molecular glue degrader plan comes unstuck, but prostate cancer work continues | ||
| 20.03. | BioNTech passes on Autolus' CD19/CD22 CAR-T amid pipeline prioritization | ||
| 20.03. | Sanofi pays $600M upfront for Dren Bio's bispecific in latest immunology play | ||
| 19.03. | UK cell therapy biotech lays off 25% of staff, turns to tool development over therapeutics | ||
| 19.03. | Flatiron Health irons out pact to bring data capture tech to National Cancer Institute trial sites | ||
| 19.03. | Dexcom survey shows healthcare providers opt for CGM tech over new medications in Type 2 diabetes | ||
| 19.03. | Synchron and Nvidia set sights on AI model trained by direct brain activity | ||
| 19.03. | Immunovant won't seek approval for autoimmune drug despite phase 3 win | ||
| 19.03. | Servier pays $70M to polish Black Diamond's deprioritized solid tumor prospect | ||
| 19.03. | Roche continues ADC dealmaking spree with $1B biobucks pact with Oxford BioTherapeutics | ||
| 18.03. | Director of NIH's National Human Genome Research Institute departs: Stat | ||
| 18.03. | Quest Diagnostics teams up with Google Cloud for gen AI customer service |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
